These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The factor V Leiden and prothrombin G20210A mutations in Kirghiz population. Gurgey A; Kudayarov DK; Tuncer M; Parlak H; Altay C Thromb Haemost; 2000 Aug; 84(2):356. PubMed ID: 10959716 [No Abstract] [Full Text] [Related]
43. Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis. van Krimpen J; Leebeek FW; Dippel DW; Gomez Garcia E Clin Neurol Neurosurg; 1999 Mar; 101(1):53-5. PubMed ID: 10350206 [TBL] [Abstract][Full Text] [Related]
44. Oral contraceptives and the risk of myocardial infarction. Tanis BC Eur Heart J; 2003 Mar; 24(5):377-80. PubMed ID: 12633537 [No Abstract] [Full Text] [Related]
45. Factor V Leiden mutation and venous thrombosis. Hatake K; Miura Y Lancet; 1995 Jan; 345(8942):133. PubMed ID: 7815876 [No Abstract] [Full Text] [Related]
46. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation. Brey RL; Coull BM Stroke; 1996 Oct; 27(10):1719-20. PubMed ID: 8841316 [No Abstract] [Full Text] [Related]
48. Cerebral venous thrombosis and activated protein C resistance. Sánchez del Rio M; Gómez-Tortosa E; Outeriño J J Neurol; 1996 Oct; 243(10):727-8. PubMed ID: 8923308 [No Abstract] [Full Text] [Related]
49. Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50. Tormene D; Simioni P; Sartori MT; Girolami A Blood Coagul Fibrinolysis; 2001 Mar; 12(2):161-2. PubMed ID: 11302480 [No Abstract] [Full Text] [Related]
50. Ischemic colitis associated with factor V Leiden mutation. Yee NS; Guerry D; Lichtenstein GR Ann Intern Med; 2000 Apr; 132(7):595-6. PubMed ID: 10744608 [No Abstract] [Full Text] [Related]
51. Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability. Vandenbroucke JP BMJ; 1998 Aug; 317(7157):483-4. PubMed ID: 9712588 [No Abstract] [Full Text] [Related]
52. Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: a case report. Vayá A; García M; Mira Y; Ferrando F; Villa P; Estellés A; Aznar J Thromb Res; 2001 Nov; 104(4):293-6. PubMed ID: 11728531 [No Abstract] [Full Text] [Related]
53. [Presence of G1691A mutation on the gene of factor V in arterial thrombosis]. Lellouche F; Dorval I; Dewilde J; Van Walleghem E Presse Med; 1995 May; 24(18):869. PubMed ID: 7638121 [No Abstract] [Full Text] [Related]
54. Cerebral venous thrombosis in young adults. Experience in a stroke unit, 1988-1994. Partziguian T; Camerlingo M; Castro L; Censori B; Gazzaniga GC; Belloni G; Mamoli A Ital J Neurol Sci; 1996 Dec; 17(6):419-22. PubMed ID: 8978448 [TBL] [Abstract][Full Text] [Related]
55. Oral contraceptives and the risk of thrombosis. Dommisse J S Afr Med J; 1979 Nov; 56(20):786. PubMed ID: 505216 [No Abstract] [Full Text] [Related]